MedPath

Oxygen

Generic Name
Oxygen
Brand Names
Alnox, Ez-OX, Heliox, Oxygen, Southern Medical
Drug Type
Small Molecule
Chemical Formula
O2
CAS Number
7782-44-7
Unique Ingredient Identifier
S88TT14065

Overview

Oxygen is an element displayed by the symbol O, and atomic number 8. It is an essential element for human survival. Decreased oxygen levels may be treated with medical oxygen therapy. Treatment with oxygen serves to increase blood oxygen levels and also exerts a secondary effect of decreasing blood flow resistance in the diseased lung, leading to decreased cardiovascular workload in an attempt to oxygenate the lungs. Oxygen therapy is used to treat emphysema, pneumonia, some heart disorders (congestive heart failure), some disorders that cause increased pulmonary artery pressure, and any disease that impairs the body's ability to take up and use gaseous oxygen. Higher level of oxygen than ambient air (hyperoxia) can be introduced under normobaric or hyperbaric conditions.

Indication

Oxygen therapy in clinical settings is used across diverse specialties, including various types of anoxia, hypoxia or dyspnea and any other disease states and conditions that reduce the efficiency of gas exchange and oxygen consumption such as respiratory illnesses, trauma, poisonings and drug overdoses. Oxygen therapy tries to achieve hyperoxia to reduce the extent of hypoxia-induced tissue damage and malfunction.

Associated Conditions

  • Anemia
  • Cancer
  • Hypoxemia
  • Hypoxia
  • Migraine
  • Polycythemia
  • Pulmonary Hypertension (PH)
  • Respiratory Disorders
  • Sleep Apnea

Research Report

Published: Jul 21, 2025

Oxygen (DB09140): A Comprehensive Monograph on its Chemistry, Pharmacology, and Clinical Application

Section I: Introduction and Historical Context: From "Dephlogisticated Air" to Essential Medicine

Oxygen, the most abundant element in the Earth's crust, occupies a unique and paradoxical position within the modern pharmacopeia. It is simultaneously a fundamental component of the atmosphere essential for all aerobic life and a potent, regulated prescription drug with a defined therapeutic window and significant potential for toxicity. This dual identity—as both a life-sustaining substrate and a powerful therapeutic agent—frames the central challenge of its clinical application: the judicious use of a substance that can be life-saving when correcting hypoxia but life-threatening when administered in excess. The journey of oxygen from an unknown component of air to a cornerstone of medical therapy is a story of scientific revolution, contested discovery, and evolving understanding that mirrors the maturation of chemistry and medicine itself. This report provides a comprehensive monograph on oxygen (DrugBank ID: DB09140), detailing its history, physicochemical properties, complex pharmacology, diverse clinical applications, methods of administration, safety profile, and the unique regulatory framework that governs its use.

The scientific understanding of oxygen emerged from an intellectual landscape dominated by the phlogiston theory. In the 18th century, this theory posited that all combustible materials contained a fire-like element called "phlogiston," which was released during burning. What we now call oxidation was then understood as the release of phlogiston, and the remaining ash or calx was considered "dephlogisticated". It was within this paradigm that the first investigations into the nature of air and combustion took place, setting the stage for one of chemistry's most pivotal discoveries.[1]

Continue reading the full research report

Clinical Trials

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Island Equipment Company
50153-110
RESPIRATORY (INHALATION)
99 L in 100 L
11/2/2023
AMERICAN GASES CORPORATION
82606-001
RESPIRATORY (INHALATION)
990 mL in 1 L
7/19/2022
Timberlake Respiratory Care and Home Medical
54292-123
RESPIRATORY (INHALATION)
99 L in 100 L
10/22/2019
Dickinson Home Medical Equipment
19979-000
RESPIRATORY (INHALATION)
1 L in 1 L
10/19/2022
A.V. Pulmonary Care
63398-1072
RESPIRATORY (INHALATION)
99 L in 100 L
1/1/2010
Monroe Welding Supply, Inc.
52233-001
RESPIRATORY (INHALATION)
992 mL in 1 L
8/24/2010
ROBINSON`S INDUSTRIAL GAS & EQUIPMENT CORP.
66487-001
RESPIRATORY (INHALATION)
997 mL in 1 L
10/10/2023
One Home Medical Equipment, LLC
73266-001
RESPIRATORY (INHALATION)
99 L in 100 L
10/20/2023
CENTRAL NEBRASKA HOME CARE SERVICES
12201-001
RESPIRATORY (INHALATION)
210 mL in 1 L
12/27/2017
Indiana Oxygen Company Inc
48546-0006
RESPIRATORY (INHALATION)
99 L in 100 L
2/11/2022

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
MEDICAL AIR
matheson gas products canada inc.
00581143
Gas - Inhalation
23.5 %
12/31/1983
PRAIRIE OXYGEN USP
prairie oxygen ltd
02312131
Gas - Inhalation
99 %
6/5/2008
OXYGEN
cair co. respiratory services inc.
02248682
Gas - Inhalation
99 %
5/3/2004
OXYGEN U.S.P.
all-can medical inc.
00896683
Gas - Inhalation
99.9 %
8/11/1990
OXYFIT GAS 99.5%
maag technic ag
00679267
Gas - Inhalation
99.5 %
12/31/1986
CARBON DIOXIDE IN OXYGEN MIXTURE
matheson gas products canada inc.
00460907
Gas - Inhalation
90 %
12/31/1983
CARBON DIOXIDE 1% W OXYGEN
liquid carbonic inc.
00882747
Gas - Inhalation
93 %
12/31/1990
LUNG DIFFUSION TEST MIXTURE
matheson gas products canada inc.
00580759
Gas - Inhalation
23 %
12/31/1982
HELIUM / OXYGEN MIXTURE
02154846
Gas - Inhalation
50 % / V/V
12/31/1995
OXYGEN USP
emrn oxygène
02242533
Gas - Inhalation
99 %
7/31/2000

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.